| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Chen,Mou | Chairman | 6.57% | QUN BEN Co., Ltd. |
| Chen,You-Ren | Director | 6.27% | YOU SHENG Co., Ltd. |
| Zhou,Meng-Xian | Director | 1.94% | ZHOU SHENG TAI Co., Ltd. |
| Guan,Zao-Xiang | Director | 0.96% | YANG YI DEVELOPMENT LTD. |
| Wang,Yu-Xiang | Independent Director | 0.00% | |
| Chen,Hua-Ming | Independent Director | 0.00% | |
| Lai,Tian-Fu | Independent Director | 0.00% |
Change Company Name to Qing Song Health Co., Ltd.
2023/09/25
Change Company Name to QINGSONG HEALTH CO., LTD. (FORMER NAME: QUNCE CO., LTD.)
2022/08/05
Change Capital to 1,200,000,000
2021/01/04
Change Capital to 500,000,000
2019/11/29
Change Person in Charge to Chen,Mou
2018/10/24
Change Company Name to Qing Song Health Co., Ltd.
2018/06/27
Change Capital to 300,000,000
2016/03/31
Change Capital to 25,000,000
2015/01/07
下載完整報告查看完整數據
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | 258,048 | 982,561 | 868,664 |
| Operating cost | 230,114 | 858,741 | 753,647 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 27,934 | 123,820 | 115,017 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 27,934 | 123,820 | 115,017 |
| Operating expenses | 23,010 | 79,742 | 61,422 |
| Other gain (loss), net | 202 | -6 | -75 |
| Operating profit (loss) | 5,126 | 44,072 | 53,520 |
| Non-operating income and expenses | -5,357 | 6,588 | 25,617 |
| Net profit (loss) before tax | -231 | 50,660 | 79,137 |
| Income tax expense (benefits) | 3,608 | 9,961 | 20,307 |
| Net profit (loss) of ongoing business for the current period | -3,839 | 40,699 | 58,830 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | -3,839 | 40,699 | 58,830 |
| Other comprehensive profit (loss), net | 191 | 916 | -59 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | -3,648 | 41,615 | 58,771 |
| Net profit (loss) attributable to owners of parent company | -3,589 | 40,551 | 59,397 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | -250 | 148 | -567 |
| Comprehensive profit (loss) attributable to owners of parent company | -3,398 | 41,467 | 59,338 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | -250 | 148 | -567 |
| Basic earnings per share (yuan) | 0 | 0 | 1 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | 9,383 | 209,967 | 20,699 |
| Net cash inflows (outflows) from investing activities | -72,568 | -134,085 | -52,061 |
| Net cash inflow (outflow) from financing activities | 406,733 | -23,802 | -61,111 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - | - |
| Increase (decrease) in cash and cash equivalents in the current period | 343,548 | 52,080 | -92,473 |
| Beginning balance of cash and cash equivalents | 286,029 | 233,949 | 326,422 |
| Ending balance of cash and cash equivalents | 629,577 | 286,029 | 233,949 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current asset | 895,723 | 476,616 | 464,070 |
| Non-current asset | 1,491,238 | 1,480,462 | 1,220,159 |
| Total asset | 2,386,961 | 1,957,078 | 1,684,229 |
| Current liability | 222,725 | 260,070 | 188,700 |
| Non-current liability | 1,043,882 | 1,024,872 | 838,666 |
| Total liability | 1,266,607 | 1,284,942 | 1,027,366 |
| share capital | 661,522 | 600,522 | 551,950 |
| Equity - secruity token | - | - | - |
| capital reserve | 392,122 | 226 | 231 |
| retained earning | 41,360 | 44,949 | 67,652 |
| Other equity | 1,111 | 920 | 4 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 1,096,115 | 646,617 | 619,837 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | 24,239 | 25,519 | 37,026 |
| Total Equity | 1,120,354 | 672,136 | 656,863 |
| Share capital awaiting retirement (unit: share) | 0 | 0 | 0 |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 16 | 10 | 11 |
